论文部分内容阅读
我院于1986年12月至1988年12月用喜得镇(Hydergin)治疗痴呆和脑血管病后智能衰退50例,现将结果报告如下: 一般资料:全部病例根据丛氏改良的长谷川式智力测验记分表筛选,选出痴呆患者后,再用Proteta-Sancher记分法鉴别出脑血管后痴呆或Alzheimer型老年痴呆,余下患者凡有卒中史和神经系统阳性体征、经长谷川式智能测验少于30分者,列为脑血管病后智能衰退,共50例作为治疗对象。对不合作、不能接受检查和未完成全部疗程者均不在统计之列。25例脑血管病后痴呆中,男23例,女2例;年龄59～75岁,平均67±5岁;病程3月～7年,平均1.3±1.5年。5例
Our hospital from December 1986 to December 1988 with Hydergin treatment of dementia and cerebrovascular disease after 50 cases of intellectual decline, the results are reported as follows: General information: All cases based on Cong improved Hasegawa Intelligence test scoring table selection, dementia patients were selected, and then use Proteta-Sancher scoring method to identify post-cerebral vascular dementia or Alzheimer’s dementia, the remaining patients who have a history of stroke and neurological positive signs, the Hasegawa-type intelligence test less At 30 points, as a smart decline after cerebrovascular disease, a total of 50 cases as treatment. Uncooperative, can not be inspected and did not complete the whole course of treatment are not included in the statistics. 25 cases of dementia after cerebrovascular disease, 23 males and 2 females; aged 59 to 75 years, mean 67 ± 5 years; duration of 3 months to 7 years, an average of 1.3 ± 1.5 years. 5 cases